Results 21 to 30 of about 156,514 (326)

Public and professional attitudes towards deceptive and open-label placebo in functional neurological disorder and wider neurological practice [PDF]

open access: diamondBMJ Neurology Open
Background Placebo effects are powerful and have been suggested to be particularly relevant in certain neurological conditions, including functional neurological disorder (FND).Methods A survey on attitudes towards and current practice of deceptive ...
Mark J Edwards   +2 more
doaj   +4 more sources

A randomized controlled trial of effects of open-label placebo compared to double-blind placebo and treatment-as-usual on symptoms of allergic rhinitis

open access: yesScientific Reports, 2023
Placebo effects are known for numerous clinical symptoms. Until recently, deception of placebos was thought to be essential for placebo effects, but intriguing new studies suggest that even placebos without concealment (open-label placebos) may help ...
Michael Schaefer   +2 more
doaj   +2 more sources

Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects [PDF]

open access: yesScientific Reports, 2022
Placebos are known to yield significant effects in many conditions. We examined deceptive and open-label placebo effects on guilt, which is important for self-regulation and a symptom of mental disorders.
Dilan Sezer, Cosima Locher, Jens Gaab
doaj   +3 more sources

Correction: Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis. [PDF]

open access: yesPLoS ONE, 2021
[This corrects the article DOI: 10.1371/journal.pone.0248367.].
Tobias Kube   +3 more
doaj   +2 more sources

The Ethics of Open-Label Placebos in Pediatrics [PDF]

open access: yesPediatrics, 2017
* Abbreviation: ADHD — : attention-deficit/hyperactivity disorder Physicians have long debated the ethics of prescribing placebos as medical therapeutics. Placebos (sham treatments such as sugar pills or saline injections) are thought to elicit improvements in clinical outcomes by mimicking medical therapies, thereby improving patients ...
Brit Trogen, A. Caplan, P. Klass
semanticscholar   +3 more sources

Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial

open access: yesFrontiers in Medicine, 2021
Introduction: Open-label placebos have been proposed as way of using long recognized analgesic placebo effects in an ethical manner. Recent evidence shows efficacy of open-label placebos for clinical conditions, but there is need for more research on ...
Dilan Sezer   +10 more
doaj   +2 more sources

"Let's see what happens:"-Women's experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial.

open access: yesPLoS ONE, 2022
Open-label (honestly prescribed) placebos are an ethical way to evoke placebo effects in patients. As part of a mixed-methods study, we conducted in-depth interviews with eight menopausal women who underwent and benefitted from open-label placebo ...
Yiqi Pan   +3 more
doaj   +2 more sources

Neural underpinnings of open-label placebo effects in emotional distress

open access: yesNeuropsychopharmacology, 2022
While placebo effects are well-known, research in the last decade revealed intriguing effects that placebos may have beneficial effects even when given without deception.
Mitchell K Schaefer   +4 more
semanticscholar   +3 more sources

The role of positive information provision in open-label placebo effects.

open access: yesApplied Psychology: Health and Well-Being, 2023
Open label placebos (OLPs) appear generally efficacious among clinical samples, but the empirical evidence regarding their use in non-clinical and sub-clinical samples, as well as when administered independent of a convincing rationale, is mixed. Healthy
K. Barnes   +4 more
semanticscholar   +3 more sources

Effects of Open-Label Placebos on Visual Food Cue Reactivity in Children and Adolescents [PDF]

open access: yesChildren
Background: A high level of food cue reactivity (FCR) is a risk factor for overeating and weight gain. This randomized trial investigated whether open-label placebos (OLPs: placebos honestly administered) can reduce FCR (reported appetite) in children ...
Anne Schienle   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy